Skip to main content

Impact BioMedical, Inc. (IBO) Stock

Impact BioMedical, Inc. Stock Details, Movements and Public Alerts

Stock Details

Impact BioMedical, Inc. (IBO), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the ASE.Currently, the stock is trading at $0.44. Over the past 52 weeks, it has ranged between $0.37 and $0.83. This places the current price at 53.0% of its 52-week high and 18.9% above its 52-week low. Recent trading volume was recorded at 51,126. The 14-day Relative Strength Index (RSI) stands at 53.18, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.48 by 8.33%. Similarly, it is below its 200-day moving average of $0.52 by 15.38%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: -0.01, Signal Line: -0.01). There is currently 1 active alert set for IBO by users.

52-Week Range

$0.83 - $0.37

-46.99% from high · +18.92% from low

Avg Daily Volume

28,023

20-day average

100-day avg: 74,849

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

0.52

Below market average

Price to Book

4.59

EV/EBITDA

-12.82

EPS (TTM)

$0.88

Price to Sales

1414.92

Q:How is IBO valued relative to its earnings and growth?
Impact BioMedical, Inc. trades at a P/E ratio of 0.52, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong.
Q:What is IBO's risk profile compared to the market?
Risk profile data is not available for this stock.

Performance & Growth

Profit Margin

2260.00%

Operating Margin

-23400.00%

EBITDA

$-3,952,000

Return on Equity

23.46%

Return on Assets

-17.79%

Revenue Growth (YoY)

-57.10%

Q:How profitable and efficient is IBO's business model?
Impact BioMedical, Inc. achieves a profit margin of 2260.00%, meaning it retains $2260.00 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of -23400.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 23.46% and ROA at -17.79%, the company generates strong returns on invested capital.
Q:What are IBO's recent growth trends?
Impact BioMedical, Inc.'s revenue declined by 57.10% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$49.5M

Revenue (TTM)

$35,000

Revenue/Share (TTM)

$0.00

Shares Outstanding

107.82M

Book Value/Share

$0.10

Asset Type

EQUITY

Q:What is IBO's market capitalization and position?
Impact BioMedical, Inc. has a market capitalization of $49.5M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 107.82M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does IBO's price compare to its book value?
Impact BioMedical, Inc.'s book value per share is $0.10, while the current stock price is $0.44, resulting in a price-to-book (P/B) ratio of 4.40. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Aug 15, 2026, 02:03 AM

Technical Indicators

RSI (14-day)

53.18

Neutral

50-Day Moving Average

$0.48

-8.33% below MA-50

200-Day Moving Average

$0.52

-15.38% below MA-200

MACD Line

-0.01

MACD Signal

-0.01

MACD Histogram

0.01

Bullish

Q:What does IBO's RSI value tell investors?
The RSI (Relative Strength Index) for IBO is currently 53.18, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret IBO's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.01 below the signal line at -0.01, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.48) is below the 200-day MA ($0.52), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Aug 15, 2026, 01:19 AM

Active Alerts

Alert Condition
MA Breakout (Bullish)
Threshold
50 days
Created
Aug 13, 2026, 04:37 PM

Stay Ahead of the Market with Impact BioMedical, Inc. Alerts

Set up price alerts for Impact BioMedical, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.